Buy or sell Mendel Biotechnology stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Mendel Biotechnology Stock

Mendel Biotechnology is a plant biotechnology company that develops genetic and chemical solutions for a range of agricultural markets.

Founded

1997

Headquarters

Hayward CA, US

Total Funding

$20.2M

About Mendel Biotechnology Stock

Mendel Biotechnology, Inc. operates as a plant biotechnology company. The company focuses on developing genetic and chemical solutions for a range of agricultural markets. It offers biofuel feedstocks, yield enhancement, flowering, drought tolerance, freezing tolerance, disease resistance, nutrient use efficiency, and cold germination products. The company has strategic partnerships with Monsanto Corporation, BP, and Bayer CropScience. Mendel Biotechnology, Inc. was founded in 1997 and is based in Hayward, California. It has operations in the United States, Europe, and China.

Funding History

June 2007$8.4M
November 2011$11.8M

Management

Sr. Vice President, Corporate Development

Greg Ikonen

Sr. Vice President, Research

Oliver J. Ratckliffe

Director, Computational Biology

Don Maszle

Director, Research

T.Lynne Reuber

Sr. Director, Research

Joshua Armstrong

Chief Financial Officer

Susan Berland

Director, Research

Peter Repetti

President and Chief Executive Officer

Neal Gutterson

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Mendel Biotechnology or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 70K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo